Alhambra Investment Management LLC
Position in GILD — Gilead Sciences, Inc.
CIK 1802696
PALMETTO BAY, FL
Position in GILD
as of Jun 30, 2026
· filed Jul 16, 2026
Position Value
$261,144
+$2,195 QoQ
Shares Held
2,067
+11.2% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.22%
of 13F equity value
Holder Rank
#1,757
of 2,266 holders
Holding Since
Dec 2022
8 quarters on record
Voting authority
Sole 32%
Shared 0%
None 68%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Alhambra Investment Management LLC holds $9,363,953 across 10 Drug Manufacturers - General names. GILD ranks #9 (2.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
8,705 | $2,210,808 | |
| 2 | AMGN |
Amgen Inc
|
4,329 | $1,567,617 | |
| 3 | MRK |
Merck & Co., Inc.
|
10,112 | $1,299,392 | |
| 4 | LLY |
ELI LILLY & Co
|
1,067 | $1,279,791 | |
| 5 | NVS |
Novartis AG
|
5,321 | $833,907 | |
| 6 | ABBV |
AbbVie Inc.
|
2,924 | $735,795 | |
| 7 | AZN |
Astrazeneca PLC
|
2,840 | $538,520 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
7,185 | $413,999 |
All Filings in GILD
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $261,144 | 2,067 | Shares | Sole | 2026-07-16 | |
| 2026-03-31 | $258,949 | 1,858 | Shares | Sole | 2026-04-15 | |
| 2025-12-31 | $234,187 | 1,908 | Shares | Sole | 2026-01-15 | |
| 2025-09-30 | $209,235 | 1,885 | Shares | Sole | 2025-10-15 | |
| 2023-12-31 | $219,618 | 2,711 | Shares | Sole | 2024-01-17 | |
| 2023-09-30 | $218,150 | 2,911 | Shares | Sole | 2023-10-17 | |
| 2023-03-31 | $214,145 | 2,581 | Shares | Sole | 2023-04-18 | |
| 2022-12-31 | $238,147 | 2,774 | Shares | Sole | 2023-01-19 | |
| No filing history on record for this holder in this stock. | ||||||